v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash Flows From Operating Activities:    
Net loss $ (96,079) $ (37,198)
Adjustments to reconcile net loss to net cash used in operating activities:    
Impairment loss 63,809  
Depreciation and amortization 22,863 20,038
Amortization of debt discount 1,622 1,928
Non-cash operating lease expense 4,391 3,403
Unrealized (gain) loss on investments in equity securities (1,445) 2,255
Realized loss on investments in equity securities 48  
Realized loss on available-for-sale investments 3,989 62
Gain on extinguishment of debt (18,505) (5,679)
Stock-based compensation expense 15,291 16,960
Loss on disposal of property and equipment 295 277
Gain on insurance settlement   (2,642)
Change in credit losses 18 (135)
Insurance proceeds for operations   1,212
Change in contingent consideration (1,329) (205)
Changes in operating assets and liabilities:    
Accounts receivable (1,075) 1,088
Inventories 2,716 (1,572)
Prepaid expenses and other current assets 454 (2,298)
Deposits 195 (652)
Operating lease liabilities (4,281) (3,009)
Accounts payable and other accrued expenses (3,022) (36)
Accrued compensation and related expenses (192) 2,013
Deferred revenue (223) 1,141
Net deferred tax liability (383) (190)
Net cash used in operating activities (10,843) (3,239)
Cash Flows From Investing Activities:    
Purchases of property and equipment (12,035) (27,212)
Insurance proceeds for loss of fixed assets   976
Software development costs (2,761) (4,830)
Purchases of short-term investments (50,721)  
Acquisitions (295)  
Sales/maturities of short-term investments 239,978 82,487
Patent and trademark costs (830) (616)
Net cash provided by investing activities 173,336 50,805
Cash Flows From Financing Activities:    
Proceeds from exercise of stock options 648 1,480
Cash paid to repurchase of 2026 Senior Notes (163,772) (25,003)
Repayment of notes payable (113) (26)
Repayment of finance lease liabilities (306) (123)
Net cash used in financing activities (163,543) (23,672)
Effect of exchange rates on cash and cash equivalents (631) (1,016)
Net change in cash and cash equivalents (1,681) 22,878
Cash and cash equivalents - beginning of period 46,346 36,595
Cash and cash equivalents - end of period 44,665 59,473
Supplemental Disclosure of Cash Flow Information:    
Cash paid for interest 629 1,792
Cash paid for income taxes 1,179 951
Supplemental Disclosure of Non-Cash Financing Activities:    
Operating lease right-of-use assets and operating lease liabilities 1,543 9,581
Net unrealized gain (loss) on available-for-sale debt securities 3,219 3,076
Reclassification of realized gain (loss) on available-for-sale debt securities to earnings (6,224) 1,389
Paid-in-kind preferred stock dividend, including beneficial conversion feature 6,000 6,000
Fixed assets included in accounts payable and accrued liabilities $ 27 $ 572

Source

10-Q PDF XBRL Zip